08:30 – 10:00 hrs | Concurrent Symposia S01-05 & Educational Sessions E05-E06
Room: Hall 3
S01.1 The quest for deep knowledge – decoding the human genome with deep learning models
Olga Troyanskaya;
United States
S01.2 Leveraging public epigenomic datasets to examine the role of regulatory variation in the three-dimensional organization of the genome
Sushmita Roy;
United States
S01.3 Combining regulatory genomics deep learning with rare-variant association tests
Uwe Ohler;
Germany
Room: Clyde
S02.1 Imaging the accessible genome at nanometer scale
James Zhe Liu;
United States
S02.2 Spatially resolved gene expression
Joakim Lundeberg;
Sweden
S02.3 Reading and visualizing single-cell genomes
Pierre Neveu;
Germany
Room: Lomond Auditorium
S03.1 Journeying through the human endovirome, from species-specific biology to precision oncology
Didier Trono;
Switzerland
S03.2 Models to study the impact of active retrotransposons on the genome
Jose Garcia-Perez;
United Kingdom
S03.3 Activation of transposons in neurological disorders
Johan Jakobsson;
Sweden
Room: Hall1
S04.1 How to transfer genomic data internationally in compliance with the GDPR
Heidi B. Bentzen;
Norway
S04.2 Is the GDPR preventing international genomic data sharing?
Jasper Bovenberg;
The Netherlands
S04.3 1+ Million Genomes Initiative and the GDPR
Regina Becker;
Luxembourg
Room: M1
S05.1 DNA damage maps
Anna Poetsch;
Germany
S05.2 DNA damage due to suppression of DNA repair in tumorigenesis
Peter Glazer;
United States
S05.3 Mutational signatures of environmental and chemotherapeutic agents in the genomes of human cells
Jill Kucab;
United Kingdom
Room: Hall 2
E05.1 Pre-emptive pharmacogenetic testing in clinical practice
Jesse J. Swen;
The Netherlands
E05.2 Pharmacogenomics: Saving lives with personalized treatment
Jatinder Lamba;
United States
Room: Hall 5
E06.1 Inherited arrhythmia syndromes
Connie R. Bezzina;
The Netherlands
E06.2 Intoduction to the arrhytmogenic disorders
Johan Saenen;
Belgium
08:30 – 10:00 hrs | Corporate Satellites
10:00 – 10:30 hrs | Coffee Break, Exhibition, Poster Viewing
10:30 – 12:00 hrs | Concurrent Sessions C08-C15 from submitted abstracts
Chairs: tba
Room: A6+A7
C08.1 Project Baby Bear: The first state-funded quality improvement project of rapid Whole Genome Sequencing in neonatal and pediatric intensive care units in the USA
Katarzyna A. Ellsworth, S. Caylor, W. Benson, C. Ashburner, J. Carmichael, E. Cham, S. Chowdhury, J. Cleary, A. D’Harlingue, L. Farnaes, J. Hunt, C. Hobbs, K. Houtchens, P. Joe, J. Knight, A. Kochhar, M. Joseph, J. Limon, M. Martin, S. Nahas, K.A. Rauen, A. Schwarz, S.P. Shankar, R. Spicer, M. Rojas, O. Vargas-Shiraishi, K. Wigby, N. Zadeh, S. Kingsmore, D. Dimmock;
San Diego, United States
C08.2 Integration of genome sequencing into health care – experiences from 3211 rare disease patients show high diagnostic rates across multiple clinical entities
Anna Lindstrand, H. Stranneheim, K. Lagerstedt-Robinson, M. Kvarnung, N. Lesko, D. Nilsson, B. Anderlid, H. Arnell, C. Backman Johansson, M. Barbaro, E. Björck, H. Bruhn, J. Eisfeldt, M. Engvall, C. Freyer, G. Grigelioniene, P. Gustavsson, A. Hammarsjö, M. Hellström-Pigg, A. Jemt, M. Laaksonen, S. Lind Enoksson, M. Magnusson, H. Malmgren, K. Naess, M. Nordenskjöld, M. Oscarson, M. Pettersson, C. Rasi, A. Rosenbaum, E. Sahlin, T. Stödberg, B. Tesi, E. Tham, H. Thonberg, U. von Döbeln, S. Vonlanthen, A. Wikström, J. Wincent, O. Winqvist, A. Wredenberg, S. Ygberg, R.H. Zetterström, P. Marits, M. Johansson-Soller, M. Johansson Soller, A. Nordgren, V. Wirta, A. Wedell;
Stockholm, Sweden
C08.3 Genomic loci susceptible to systematic sequencing bias in clinical whole genomes
Timothy M. Freeman*, Genomics England Research Consortium, D. Wang, J. Harris;
Sheffield, United Kingdom
C08.4
Systematic analysis of short tandem repeats in 38,256 exomes provides additional diagnostic yield
Bart P.G.H. van der Sanden*, M. de Groot, J. Corominas, M. Pennings, R.P.P. Meijer, L.E.L.M. Vissers, E. Kamsteeg, C. Gilissen;
Nijmegen, Netherlands
C08.5 A cost-effectiveness and utility analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients
Alison Yeung, N.B. Tan, T.Y. Tan, Z. Stark, N. Brown, M.J. Hunter, M. Delatycki, C. Stutterd, R. Savarirayan, G. McGillivray, R. Stapleton, S. Kumble, L. Downie, M. Regan, S. Lunke, B. Chong, D. Phelan, G. Brett, A. Jarmolowicz, Y. Prawer, G. Valente, Y. Samarinsky, M. Martin, C. McEwan, I. Goranitis, C. Gaff, S.M. White;
Parkville, Australia
C08.6 The impact of the 100,000 Genomes Project on rare disease in national healthcare
Damian Smedley, S. Abbs, G. Arno, E. Baple, M. Barnes, P. Beales, M. Bitner-Glindzicz, G. Black, P. Brennan, G. Chan, P. Chinnery, V. Cipriani, S. Ellard, J. Ellingford, P. Elliott, H. Firth, F. Flintner, K. Ibanez Garikano, H. Houlden, M. Irving, J. Jacobsen, E. McDonagh, D. McMullan, L. Moutsianas, W. Newman, W.H. Ouwehand, T. Ratnaike, A. Rueda Martin, C. Penkett, F. Raymond, J. Sayer, R. Scott, K. Smith, H. Stark, K. Stirrups, J. Taylor, E. Thomas, A. Tucci, J. Vandrovcova, L. Vestito, A. Webster, W. Wei, M. Wielscher, H. Williams, A. Wilkie, C. Wright, A. Rendon, M. Caulfield, ,. NIHR BioResource, ,. Genomics England Research Consortium;
London, United Kingdom
Chairs: tba
Room: A8
C09.1 The Australian Genomic Health Alliance Mitochondrial Flagship – A national approach to genomic diagnostics
David Thorburn, N. Baker, S. Balasubramaniam, D. Bratkovic, D. Coman, A. Compton, M. Delatycki, C. Ellaway, M. Fahey, J. Fletcher, A. Frazier, R. Ghaoui, H. Goel, D. Hock, M. Kava, N. Lake, P. Lamont, J. Lee, J. Panetta, L. Phillips, R. Rius, M. Ryan, N. Smith, D. Stroud, M. Tchan, M. Walsh, M. Wallis, A. Welch, C. Wools, J. Christodoulou;
Melbourne, Australia
C09.2 High resolution respirometric analysis of a Barth Syndrome disease model
Gregor Oemer*, K. Lackner, J. Koch, E.R. Werner, C. Doerrier, G. Krumschnabel, G. Leman, S. Dubrac, R. Houtkooper, J. Zschocke, M.A. Keller;
Innsbruck, Austria
C09.3 Recurrent de novo ATAD3 duplications cause fatal perinatal mitochondrial cardiomyopathy, persistent hyperlactacidemia, encephalopathy and heart-specific mitochondrial oxidative phosphorylation complex I deficiency.
A.E. Frazier, Alison G. Compton, Y. Kishita, D.H. Hock, A.E. Welch, S.S.C. Amarasekera, R. Rius, L.E. Formosa, A. Imai-Okazaki, D. Francis, M. Wang, N.J. Lake, S. Tregoning, J.S. Jabbari, A. Lucattini, K.R. Nitta, A. Ohtake, K. Murayama, D.J. Amor, G. McGillivray, F.Y. Wong, M.S. van der Knaap, R.J. Vermeulen, E.J. Wiltshire, J.M. Fletcher, B. Lewis, G. Baynam, C. Ellaway, S. Balasubramaniam, K. Bhattacharya, M.L. Freckmann, R.J. Taft, S. Sadedin, M.J. Cowley, A.E. Minoche, S.E. Calvo, V.K. Mootha, M.T. Ryan, Y. Okazaki, D.A. Stroud, C. Simons, J. Christodoulou, D.R. Thorburn;
Melbourne, Australia
C09.4 Hyperuricemia and gout caused by missense mutation in D-lactate dehydrogenase, revealing novel enzymatic activity
Max Drabkin*, Y. Yogev, L. Zeller, R. Zarivach, R. Zalk, D. Halperin, O. Wormser, E. Gurevich, D. Landau, R. Kadir, Y. Perez, O.S. Birk;
Beer-Sheva, Israel
C09.5 Metabolite set enrichment improves biomarker identification and detection in untargeted metabolic profiling (UMP) data for patients with inborn errors of metabolism
Brechtje Hoegen*, U.F.H. Engelke, K.L.M. Coene, J.E. Hampstead, P. Kulkarni, R.A. Wevers, H.G. Brunner, C. Gilissen;
Nijmegen, Netherlands
C09.6 A genome-wide association study for a proxy non-alcoholic fatty liver phenotype identifies novel loci and trait-relevant candidate genes
M. Vujkovic, S. Ramdas, K. Gawronski, K. Lorenz, M. Serper, D.E. Kaplan, R. Carr, K.M. Lee, S. Saiju Pyarajan, T. Edwards, D. Klarin, Y.V. Sun, D.R. Miller, P.D. Reaven, L.S. Phillips, C.J. O’Donnell, J.B. Meigs, P.W.F. Wilson, R. Vickers-Smith, H.R. Kranzler, A.C. Justice, M. Gaziano, S. Muralidhar, S.L. DuVall, T.L. Assimes, J.S. Lee, P.S. Tsao, D.J. Rader, C.D. Brown, S.M. Damrauer, J.A. Lynch, D. Saleheen, Benjamin F. Voight, K.M. Chang, on behalf of the VA Million Veteran Program;
Philadelphia, United States
Chairs: tba
Room: A3
C10.1 Recessive vs dominant GWAS of 82,516 coding variants on electronic health records in a population-wide analysis of 176,899 Finns
Henrike O. Heyne, J. Karjalainen, S.M. Lemmelä, FinnGen, A.S. Havulinna, M. Kurki, A. Palotie, M.J. Daly;
Helsinki, Finland
C10.2 Germline genetic testing following tumor sequencing in cancer patients has a remarkably high yield of clinically important findings that inform patient care
Stephen Lincoln, K. Das, N. Ngo, S. Michalski, S. Yang, D. Pineda, E. Esplin, S. Aradaya, R. Nussbaum;
San Francisco, United States
C10.3 The first genotype-phenotype study on European carriers of CDH1 germline mutations
José García-Peláez*, R. Monteiro, L. Sousa, H. Pinheiro, S. Castedo, L. Garrido, M. Teixeira, G. Michils, V. Bours, R. de Putter, L. Golmard & M. Blanluet, C. Colas, P. Benusiglio, S. Aretz & I. Spier, R. Hüneburg, L. Gieldon, E. Schröck, E. Holinski-Feder & V. Steinke, D. Calistri & G. Tedaldi, G. Ranzani, M. Genuardi, C. Silveira & I. Silva, M. Krajc & A. Blatnik, S. Novakovic, A. Patiño-García, J. Soto, C. Lázaro, G. Capellá, J. Brunet-Vidal, J. Balmaña, E. Domínguez-Garrido, M. Ligtenberg, E. Fewings, R. Fitzgerald, E. Woodward, G. Evans, H. Hanson, K. Lagerstedt-Robinson, S. Bajalica-Lagercrantz, C. Egas, C. Martínez-Bouzas et al., K. Dahan & D. Feret, N. Hoogerbrugge, M. Tischkowitz, C. Oliveira;
Porto, Portugal
C10.4 Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of 5182 cases from long QT syndrome and Brugada syndrome consortia cohorts and gnomAD population controls
Roddy Walsh, N. Lahrouchi, C. Glinge, C. Krijger, D. Skoric-Milosavljevic, N. Whiffin, F. Mazzarotto, J.S. Ware, R. Tadros, International Brugada Syndrome Genetics Consortium, International LQTS Genetics Consortium, C.R. Bezzina;
Amsterdam, Netherlands
C10.5 Genome wide association study based on cardiac magnetic resonance imaging in 23,634 individuals identifies five new loci associated with left atrial enlargement
Gustav Ahlberg*, L. Andreasen, J. Ghouse, S. Haunsoe, J.H. Svendsen, M.S. Olesen;
Copenhagen, Denmark
C10.6 Genetic interactions modulate lipid plasma levels and cellular uptake
Magdalena Zimon;, Y. Huang, A. Trasta, J. Liu, C. Chen, A. Halavatyi, P. Blattmann, B. Klaus, C. Whelan, D. Sexton, S. John, E. Tsai, W. Huber, R. Pepperkok, H. Runz;
Heidelberg, Germany
Chairs: tba
Room: A2
C11.1 Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism
Nadja Ehmke, K. Cusmano-Ozog, R. Koenig, M. Holtgrewe, B. Nur, E. Mihci, H. Babcock, C. Gonzaga-Jauregui, J.D. Overton, J. Xiao, B. Fischer-Zirnsak, C. Huber, U. Kornak, S.H. Elsea, V. Cormier-Daire, C.R. Ferreira;
Berlin, Germany
C11.2 Integrated genome and transcriptome analyses solves about one third of the patients with rare developmental disorders and negative first-line molecular investigations
Antonio Vitobello, F. Tran Mau-Them, A.L. Bruel, Y. Duffourd, E. Tisserant, P. Callier, S. Moutton, S. Nambot, D. Lehalle, N. Jean-Marçais, J. Delanne, C. Racine, J. Thevenon, C. Poe, T. Jouan, M. Chevarin, M. Willems, C. Coubes, D. Geneviève, N. Houcinat, A. Masurel-Paulet, A. Mosca-Boidron, A. Sorlin, B. Isidor, S. Heide, A. Afenjar, D. Rodriguez, C. Mignot, D. Heron, M. Vincent, P. Charles, S. Odent, C. Dubourg, A. Faudet, B. Keren, B. Cogné, A. Boland, R. Olaso, C. Philippe, J.F. Deleuze, L. Faivre, C. Thauvin-Robinet;
Dijon, France
C11.3 Characterization and treatment of overactive KATP channels associated with Cantú syndrome in zebrafish
Helen I. Roessler*, S.S. Singareddy, C. McClenaghan, S. Savelberg, F. Tessadori, J. Bakkers, R. Tyron, C.G. Nichols, G. van Haaften;
Utrecht, Netherlands
C11.4 Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder
Pauline E. Schneeberger*, F. Kortüm, G.C. Korenke, M. Alawi, R. Santer, M. Woidy, D. Buhas, S. Fox, D. McKnight, M. Alfadhel, B.D. Webb, E.G. Coci, R. Abou Jamra, A. Finck, M. Siekmeyer, S. Biskup, C. Heller, E.M. Maier, P. Javaher-Haghighi, M.F. Bedeschi, P.F. Ajmone, M. Iascone, H. Peeters, K. Ballon, J. Jaeken, A. Rodríguez Alonso, M. Palomares-Bralo, F. Santos-Simarro, M.E.C. Meuwissen, D. Beysen, R. Kooy, H. Houlden, D. Murphy, M. Doosti, E.G. Karimiani, M. Mojarrad, R. Maroofian, B.D. Gelb, I. Kurth, M. Hempel, K. Kutsche;
Hamburg, Germany
C11.5 C’-terminal lacking MN1 variants gain the function leading craniofacial and brain abnormalities in human
Noriko Miyake, H. Takahashi, K. Nakamura, B. Isidor, Y. Hiraki, Y. Kimura, S. Tomizawa, N. Matsumoto;
Yokohama, Japan
C11.6 A novel Bannayan-Riley-Ruvalcaba (BRRS)/CLOVES syndrome model in Xenopus tropicalis, by CRISPR/Cas9
Dionysia Dimitrakopoulou, S. Demuynck, K. Vleminckx;
Ghent, Belgium
Chairs: tba
Room: A1
C12.1 Polygenic background of psychotic disorders and genetic determinants of disease severity
Ari V. Ahola-Olli, Z. Misiewicz, N. Mars, M. Lähteenvuo, B. Neale, T. Männynsalo, E. Isometsä, A. Wegelius, J. Hietala, W. Haaki, O. Kampman, J. Veijola, J. Tiihonen, T. Kieseppä, J. Suvisaari, S. Hyman, M. Daly, A. Palotie;
Cambridge, United States
C12.2 Autism-linked Cullin3 germline haploinsufficiency impacts cytoskeletal dynamics and cortical neurogenesis through RhoA signaling
M. Amar, A. Pramod, V. Munive Herrera, N. Yu, L.R. Qiu, P. Moran-Losada, P. Zhang, C.A. Trujillo, J. Ellegood, J. Urresti, K. Chau, J. Diedrich, J. Chen, J. Gutierrez, J. Sebat, D. Ramanathan, J.P. Lerch, J.R. Yates III, A.R. Muotri, Lilia M. Iakoucheva;
La Jolla, United States
C12.3 Tissue-specific transcriptional and functional signatures in reciprocal genomic disorders : Insights from integrated mouse and human neuronal models
Rachita Yadav*, D. JC Tai, J. Wang, T. Aneichyk, S. Erdin, B. B Currall, K. O’Keefe, A. Stortchevoi, U. Rudolph, R. H. Perlis, J. F Gusella, M. E Talkowski;
Boston, United States
C12.4 Autism Comorbidities: Role of CHD8 during the Development of the Enteric Nervous System
Gaëlle L. Hayot*, C. Weber, C. Golzio;
Illkirch-Graffenstaden, France
C12.5 A human single-cell atlas of the Substantia nigra reveals novel cell-specific pathways associated with the genetic risk of Parkinson’s disease and neuropsychiatric disorders.
D. Agarwal, C. Sandor, V. Volpato, T. Caffrey, J. Monzon-Sandoval, R. Bowden, J. Alegre-Abarrategui, R. Wade-Martins, Caleb Webber;
Cardiff, United Kingdom
C12.6 Clinical and molecular complexity of X-linked clustering epilepsy, a disorder of cellular mosaics
Jozef Gecz, K. Kolc, L. Sadleir, C. Depienne, C. Marini, I.E. Scheffer, R.S. Moller, M. Trivisano, N. Specchio, R. Kumar, D. Pham, R. Roberts;
Adelaide, Australia
Chairs: tba
Room: A5
C13.1 Landscape of cohesin-mediated chromatin loops in the human genome
Fabian Grubert, R. Srivas, D. Spacek, M. Kasowski, M. Ruiz-Velasco, N. Sinnott-Armstrong, P. Greenside, A. Narasimha, Q. Liu, B. Geller, A. Sanghi, M. Kulik, S. Sa, M. Rabinovitch, A. Kundaje, S. Dalton, J. Zaugg, M. Snyder;
Stanford, United States
C13.2 Analysis of chromatin looping at joint endometrial-ovarian cancer risk loci to identify candidate target genes
Dylan Glubb, I. Jeong, A. Spurdle, T. O’Mara;
Brisbane, Australia
C13.3 When the silent genome gets loud: transcription of repeated genomic elements at the single-cell resolution in K27M-mutated high-grade gliomas
Marie Coutelier*, V. Lisi, S. Hébert, D. Faury, B. Krug, N. De Jay, N. Jabado, C.L. Kleinman;
Montreal, Canada
C13.4 CDH1 regulatory noncoding elements: a hidden master for tissue-specific E-cadherin expression
Celina São José*, A.R. Monteiro, A. Qamra, R. Acuna-Hidalgo, P. Tan, S. Mundlos, C. Oliveira;
Porto, Portugal
C13.5 Local gene co-expression: molecular characterisation, tissue specificity and its genetic control
Diogo Ribeiro*, A. Ramisch, E. Dermitzakis, O. Delaneau;
Lausanne, Switzerland
C13.6 Structural variants in HDAC9 that disrupt TWIST1 transcriptional regulation but not HDAC9 protein function are associated with craniofacial and limb malformations
Ramon Y. Birnbaum, N. Hirsch;
Beer-Sheva, Israel
Chairs: tba
Room: A4
C14.1 Implication of FOXD2 in autosomal recessive syndromic CAKUT
Korbinian M. Riedhammer, M. Nguyen, B. Alhaddad, S.J. Arnold, G.J. Kim, U. Heemann, M. Schmidts, J. Hoefele;
Munich, Germany
C14.2 Heterozygous DACT1 mutations in patients with renal anomalies and features of Townes-Brocks syndrome
A. Christians, E. Kesdiren, I. Hennies, A.D. Hofmann, M. Trowe, F. Brand, Helge Martens*, I.A. Kindem, Z. Gucev, M. Zirngibl, R. Geffers, T. Seeman, A. Kispert, H. Billing, A. Bjerre, V. Tasic, D. Haffner, J. Dingemann, R.G. Weber;
Hannover, Germany
C14.3 Loss of UNC45A causes microvillus inclusion disease-like by impairing myosin-dependent epithelial morphogenesis
R. Duclaux-Loras, F. Charbit-Henrion, C. Lebreton, O. Nicolle, M. Rabant, C. Guerrera, A. Fabre, L. Faivre, G. Michaux, H. Uligh, F. Ruemmele, N. Cerf-Bensussan, Marianna Parlato;
Paris, France
C14.4 A comprehensive exome study of the genetic architecture of asthma reveals a putative novel patient subgroup defined by filaggrin truncating variants
Sophia R. Cameron-Christie*, H. Olsson, A. Mackay, Q. Wang, M. Hühn, D. Muthas, G. Lassi, J. Lindgren, G. Povysil, D.B. Goldstein, G. Belfield, I. Dillmann, Y. Ohne, S. Cohen, S. Young, A. Platt, S. Petrovski;
Cambridge, United Kingdom
C14.5 Random plasma glucose GWAS in 479,678 individuals: genetic relationships with impaired lung function and intestinal health
Marika A. Kaakinen, L. Jiang, A. Ulrich, L. Zudina, Z. Balkhiyarova, P. Todorov, T.H. Pers, V. Lagou, I. Prokopenko, MAGIC Investigators;
Guildford, United Kingdom
C14.6 A complementary study approach unravels novel players in the pathoetiology of Hirschsprung‘s disease
T. Mederer, Stefanie Schmitteckert, J. Volz, C. Martinez, R. Röth, T. Thumberger, V. Eckstein, J. Scheuerer, C. Thöni, F. Lasitschka, L. Carstensen, P. Günther, S. Holland-Cunz, R. Hofstra, E. Brosens, D. Schriemer, I. Ceccherini, M. Rusmini, J. Tilghman, B. Luzón-Toro, A. Torroglosa, S. Borrego, C. Szeman Tang, M. Garcia-Barcelo, P. Tam, N. Paramasivam, M. Bewerunge-Hudler, C. de la Torre, N. Gretz, G. Rappold, P. Romero, B. Niesler;
Heidelberg, Germany
Chairs: tba
Room: Live Stream Area (Exhibition Hall)
More information will follow soon.
12:00 – 13:00 hrs | Lunch Break, Exhibition, Poster Viewing
12:00 – 13:00 hrs | Corporate Satellites
13:00 – 14:00 hrs | Poster Viewing with Authors – Group A
14:15 – 15:45 hrs | Workshops W05-W11
More information will follow in spring 2021.
More information will follow in spring 2021.
More information will follow in spring 2021.
More information will follow in spring 2021.
More information will follow in spring 2021.
More information will follow in spring 2021.
More information will follow in spring 2021.
14:15- 15:45 hrs | Corporate Satellites
15:45 – 16:00 hrs | Fruit Break, Exhibition, Poster Viewing
16:00 – 17:00 hrs | Poster Viewing with Authors – Group B
17:15 – 18:45 hrs | Concurrent Symposia S06-09 & Educational Sessions E07-E09
Room: Hall 2
S06.1 Transcriptional programs of brain tumors
Claudia Kleinman;
Canada
Room: Hall 5
S07.1 Rapid evolution of genome regulation in mammals
Duncan Odom;
Germany
S07.2 Leveraging massive-scale population genomics data to unveil functional constraints
Daniel MacArthur;
Australia
S07.3 Cross-species analysis of regulatory elements and logic using deep learning
Stein Aerts;
Belgium
Room: Hall 1
S08.1 Ancestry characterization of the Chilean population and its relevance to health
Ricardo Verdugo;
Chile
S08.2 The Mexico Biobank Project
Andrès Moreno;
Mexico
S08.3 Ethics and inclusivity when working with indigenous populations
Emma Kowal;
Australia
Room: M1
S09.1 AAV gene therapy for glycogen storage diseases
Dwight Koeberl;
United States
S09.2 mRNA replacement therapy for inborn errors of liver metabolism
Paolo Martini;
United States
S09.3 Lentiviral vectors for liver-directed gene therapy
Alessio Cantore;
Italy
Room: Hall 3
E07.1 Using genomic resources to interpret the clinical significance of rare variants
Heidi Rehm;
United States
E07.2 Intepretation of the non-protein-coding regions of the genome
Nicky Whiffin;
United Kingdom
Room: Clyde
E08.1 Status of PGT and embryo selection in the era of NGS
Antonio Capalbo;
Italy
E08.2 Good practice recommendations for the PGT applications
Martine De Rycke;
Belgium
Room: Lomond Auditorium
E09.1 AI in genomics: the present and the future
Julien Gagneur;
Germany
E09.2 Policy, ethical, legal and social issues of AI use in genomics
Sobia Raza ;
United Kingdom